Jennifer J Rhodes - Net Worth and Insider Trading
Jennifer J Rhodes Net Worth
The estimated net worth of Jennifer J Rhodes is at least $2 Million dollars as of 2024-11-08. Jennifer J Rhodes is the GC & Corporate Secretary of Medivation Inc and owns about 22,180 shares of Medivation Inc (MDVN) stock worth over $2 Million. Jennifer J Rhodes is the CBO, GC & Compliance Officer of Adamas Pharmaceuticals Inc and owns about 63,114 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $518,797. Jennifer J Rhodes is also the See Remarks of Angion Biomedica Corp and owns about 3,040 shares of Angion Biomedica Corp (ANGN) stock worth over $30,400. Details can be seen in Jennifer J Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer J Rhodes has not made any transactions after 2021-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer J Rhodes
Jennifer J Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer J Rhodes owns 4 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Medivation Inc (MDVN) , and Angion Biomedica Corp (ANGN) among others .
Click here to see the complete history of Jennifer J Rhodes’s form 4 insider trades.
Insider Ownership Summary of Jennifer J Rhodes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2019-06-20 | CBO & GC & Compliance Officer |
| MDVN | Medivation Inc | 2015-03-16 | GC & Corporate Secretary |
| ANGN | Angion Biomedica Corp | 2021-12-14 | See Remarks |
 | | 2021-02-04 | See Remarks |
Jennifer J Rhodes Latest Holdings Summary
Jennifer J Rhodes currently owns a total of 3 stocks. Among these stocks, Jennifer J Rhodes owns 22,180 shares of Medivation Inc (MDVN) as of March 16, 2015, with a value of $2 Million and a weighting of 76.68%. Jennifer J Rhodes owns 63,114 shares of Adamas Pharmaceuticals Inc (ADMS) as of June 20, 2019, with a value of $518,797 and a weighting of 22.02%. Jennifer J Rhodes also owns 3,040 shares of Angion Biomedica Corp (ANGN) as of December 14, 2021, with a value of $30,400 and a weighting of 1.29%.
Latest Holdings of Jennifer J Rhodes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDVN | Medivation Inc | 2015-03-16 | 22,180 | 81.44 | 1,806,339 |
| ADMS | Adamas Pharmaceuticals Inc | 2019-06-20 | 63,114 | 8.22 | 518,797 |
| ANGN | Angion Biomedica Corp | 2021-12-14 | 3,040 | 10.00 | 30,400 |
Holding Weightings of Jennifer J Rhodes
Jennifer J Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 2,780 shares on March 16, 2015, which brought Jennifer J Rhodes around $181,979.
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 940 shares on June 20, 2019, which brought Jennifer J Rhodes around $5,029.
According to the SEC Form 4 filings, Jennifer J Rhodes has made a total of 11 transactions in Angion Biomedica Corp (ANGN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Angion Biomedica Corp is the sale of 45 shares on December 14, 2021, which brought Jennifer J Rhodes around $1,091.
Insider Trading History of Jennifer J Rhodes
- 1
Jennifer J Rhodes Trading Performance
Jennifer J Rhodes Ownership Network
Ownership Network List of Jennifer J Rhodes
Ownership Network Relation of Jennifer J Rhodes
Jennifer J Rhodes Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Jennifer J Rhodes is the CBO & GC & Compliance Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Jennifer J Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer J Rhodes. You might contact Jennifer J Rhodes via mailing address: C/o Adamas Pharmaceuticals Inc., 1900 Powell St., Suite 750, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
